Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
25
pubmed:dateCreated
2009-6-22
pubmed:abstractText
We hypothesized that erythropoietin (EPO)-immersed gelatin hydrogel microspheres (GHM) injected into ischemic legs might continuously release a small amount of EPO to locally stimulate angiogenesis without unfavorable systemic effects.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1558-3597
pubmed:author
pubmed:issnType
Electronic
pubmed:day
23
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2378-88
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19539150-Adult Stem Cells, pubmed-meshheading:19539150-Angiogenesis Inducing Agents, pubmed-meshheading:19539150-Animals, pubmed-meshheading:19539150-Cells, Cultured, pubmed-meshheading:19539150-Delayed-Action Preparations, pubmed-meshheading:19539150-Endothelial Cells, pubmed-meshheading:19539150-Erythropoietin, pubmed-meshheading:19539150-Hydrogels, pubmed-meshheading:19539150-Ischemia, pubmed-meshheading:19539150-Lower Extremity, pubmed-meshheading:19539150-Male, pubmed-meshheading:19539150-Mice, pubmed-meshheading:19539150-Mice, Inbred BALB C, pubmed-meshheading:19539150-Microspheres, pubmed-meshheading:19539150-Myocytes, Smooth Muscle, pubmed-meshheading:19539150-Neovascularization, Physiologic, pubmed-meshheading:19539150-Peripheral Vascular Diseases, pubmed-meshheading:19539150-Receptors, Erythropoietin, pubmed-meshheading:19539150-Recombinant Proteins, pubmed-meshheading:19539150-Regional Blood Flow
pubmed:year
2009
pubmed:articleTitle
Sustained release of erythropoietin using biodegradable gelatin hydrogel microspheres persistently improves lower leg ischemia.
pubmed:affiliation
Division of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't